Lantheus (LNTH) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
20 Mar, 2026Executive summary
Annual meeting scheduled for April 30, 2026, with both in-person and virtual attendance options.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report, are available online and by request.
Voting matters and shareholder proposals
Election of four Class II directors is up for shareholder vote.
Advisory vote on executive compensation ("say on pay") and on the frequency of future say-on-pay votes.
Proposal to amend the Certificate of Incorporation to declassify the Board of Directors.
Approval of the 2026 Amended and Restated Equity Incentive Plan is on the agenda.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
Board of directors and corporate governance
Board recommends voting for all director nominees and for declassifying the Board.
Four nominees for Class II director positions are presented for election.
Latest events from Lantheus
- Proxy covers director elections, compensation, board declassification, and equity plan expansion.LNTH
Proxy filing20 Mar 2026 - Transition to new radiodiagnostics and operational focus set up for growth in 2026 and beyond.LNTH
Leerink Global Healthcare Conference 202610 Mar 2026 - Strategic focus shifts to diagnostics, with new launches and disciplined capital allocation ahead.LNTH
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - 2026 guidance: $1.4–$1.45B revenue, $5.00–$5.25 EPS, and new PET launches expected in 2027.LNTH
Q4 202526 Feb 2026 - Decades of expertise and robust supply chains drive innovation and leadership in radiopharmaceuticals.LNTH
TD Cowen 2nd Annual Radiopharmaceutical Innovation Summit3 Feb 2026 - Q2 2024 revenue up 22.5% to $394.1M, led by PYLARIFY, with EPS up and pipeline expanded.LNTH
Q2 20242 Feb 2026 - PYLARIFY's strong growth and pipeline advances position the company for radiopharmaceutical leadership.LNTH
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Disciplined M&A and blockbuster PYLARIFY fuel growth as new assets and reimbursement wins drive expansion.LNTH
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Blockbuster diagnostics, pipeline expansion, and isotope innovation drive leadership.LNTH
2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026